Product Description
The global robotic vascular catheter system market was valued at $250 million in 2024. This is expected to increase over the forecast period at a CAGR of 12.6% to reach $570 million
The full report suite on the global market for robotic vascular catheter systems includes three segments: capital equipment, disposables and other accessories and services and maintenance revenue. Regional procedure volumes using robotic vascular catheters are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ROBOTIC VASCULAR CATHETER SYSTEM MARKET TRENDS
A major driver in the robotic vascular catheter system market is the capability to conduct remote surgeries. Since 2018, devices in this segment have been used to conduct remote procedures, which may contribute to the increase in robotic adoption of vascular catheter procedures. The COVID-19 pandemic has highlighted the importance of access to remote medical care, making remote surgery an attractive option for both patients and surgeons.
GLOBAL ROBOTIC VASCULAR CATHERTER SYSTEM MARKET SHARE INSIGHTS
- Johnson & Johnson, through its subsidiary, Auris Health, led the global robotic vascular catheter system market in 2024 through its acquisition of Hansen Medical in 2016. The company markets a range of robotic vascular catheters and accessories, including the Magellan™, Sensei® and Artisan® Extend Control Catheter
- Stereotaxis is the second-leading position in the global robotic vascular catheter system market in 2021. It markets several devices, including the Vdrive® Robotic Navigation System, which is marketed with the Niobe® Robotic Magnetic Navigation System, Odyssey VisIon™ System and Genesis RMN® System. More recently, Stereotaxis developed MAGiC™, a robotically navigated magnetic interventional catheter that received Conformité Européenne (CE) mark approval in July 2022.
- Siemens Healthineers company, through its subsidiary, Corindus Vascular Robotics, held the third-leading position in the robotic vascular catheter system market globally. The company offers its next-generation vascular robotic system, CorPath® GRX, which is based off the company’s original system, CorPath® Vascular Robotic System. Corindus’ CorPath® GRX system was involved in an Indian study where the first ever remote percutaneous coronary interventions (PCIs) were performed successfully. However, in 2023, Siemens Healthineers announced that its endovascular robotic solution will focus exclusively on interventional neurology and halt from the robotic cardiovascular business.
GLOBAL ROBOTIC VASCULAR CATHERTER SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment Market
- Limited Use Accessories Market
- Services and Maintenance Revenue Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
